期刊論文1. | 吳俊穎(20090900)。醫師告知義務急速擴張的時代--法界的期待與醫界的臨床實務之間的鴻溝。法學新論,14,87-111。 延伸查詢 |
2. | 楊麗珍、楊志勛、鐘文宏(2011)。過敏藥物之藥物基因體學與藥物基因檢測。長庚醫訊,32(9),12-15。 延伸查詢 |
3. | Hung, S. I.、Chung, W. H.、Liou, L. B.、Chu, C. C.、Lin, M.、Huang, H. P.(2005)。HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol。Proceedings of the National Academy of Sciences of the United States of America,102(11),4134-4139。 |
4. | Biagi, Karen G.(1991)。Moore v. Regents of the University of California: Patients, Property Rights, and Public Policy。Saint Louis University Law Journal,35。 |
5. | 楊佳芳、吳至行(20010100)。痛風病人處置建議的最新準則。基層醫學,16(1),20-27。 延伸查詢 |
6. | Chung, Wen-Hung、Hung, Shuen-Iu、Hong, Hong-Shang、Hsih, Mo-Song、Yang, Li-Cheng、Ho, Hsin-Chun、Wu, Jer-Yuarn、Chen, Yuan-Tsong(2004)。Medical Genetics: A Marker for Stevens-Johnson Syndrome。Nature,428(6982)。 |
7. | 何建志(20080100)。藥物基因體學之政策與法律議題分析。法律與生命科學,4,1-17。 延伸查詢 |
8. | Sachidanandam, Ravi、Weissmann, David、Schmidt, Steven C.、Kakol, Jerzy M.、Stein, Lincoln D.、Marth, Gabor、Sherry, Stephen T.、Mullikin, James C.、Mortimore, Beverley J.、Willey, David L.(2001)。A Map of Human Genome Sequence Variation Containing 1.42 Million Single Nucleotide Polymorphisms。Nature,409,928-933。 |
9. | Mandry, Tilo(2004)。Legal Implications of Pharmacogenomics Regarding Drug Trials, Drug Labeling, and Genetic Testing for Drug Prescription: An International Approach。Food and Drug Law Journal,59(4),519-535。 |
10. | Solensky, Roland(2006)。Drug Hypersensitivity。Medical Clinics of North America,90(1),235-236。 |
11. | Baker, John(1997)。Tardive Dyskinesia: Reducing Medical Malpractice Exposure Through a Risk-Benefit Analysis。DePaul Journal of Health Care Law,1,836-837。 |
12. | 張孟媛(2004)。嚴重藥物過敏,可以預防。科學人雜誌,27,13-14。 延伸查詢 |
13. | 遲蘭慧、高純琇、回德仁(2005)。藥害救濟案例分析--Allopurinol。藥物安全簡訊,13。 延伸查詢 |
14. | 王雅玲(2002)。正確使用抗生素。高醫醫訊月刊,22(3)。 延伸查詢 |
15. | Binzak, Barbara A.(2003)。How Pharmacogenomics will Impact the Federal Regulation of Clinical Trials and the New Drug Approval Process。Food and Drug Law Journal,58,103-104。 |
16. | Evans, William E.、McLeod, Howard L.(2003)。Pharmacogenomics Drug Disposition, Drug Targets, and Side Effects。The New England Journal of Medicine,348,538-549。 |
17. | Fuchs, Susan A.(2010)。Will the FDA's 2010 Warfarin Label Changes Finally Provide the Legal Impetus for Warfarin Pharmacogenetic Testing?。NC Journal of Law & Technology,12。 |
18. | Donovan, Michael J.(2010)。Legal Issues Stemming from the Advancement of Pharmacogenomics。UCLA Journal of Law & Technology,14(1),31-65。 |
19. | 梁金銅(20061000)。簡介大腸直腸癌基因多型性與抗癌藥物基因體學。臺灣醫界,49(10),10-13。 延伸查詢 |
20. | 陳聰富(20090600)。告知後同意與醫師說明義務。月旦法學教室,80,75-91。 延伸查詢 |
21. | Tietz, Gerald F.(1986)。Informed Consent in the Prescription Drug Context: The Special Case。Washington Law Review,61(2),367-417。 |